Bausch Health Companies Inc. (BHC) shareholders
Close on Nov 17, 2026Market cap $3.17BP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Paulson & Co. Inc. | 70,755,869 | 19.10% | 13D (active) amendment | Aug 14, 2025 |
| Alex Meruelo | 36,761,788 | 9.99% | 13D (active) | Mar 31, 2025 |
| Steven A. Tananbaum Joint filing with GoldenTree Asset Management LP (9.30%), GoldenTree Asset Management LLC (9.30%) | 35,243,712 | 9.50% | 13G (passive) amendment | Jun 30, 2025 |
| Icahn Capital LP Joint filing with Icahn Enterprises Holdings L.P. (9.40%), Beckton Corp. (9.40%) and 5 more | 34,721,118 | 9.40% | 13D (active) amendment | May 20, 2025 |
| Nomura Holdings Inc Joint filing with Nomura Global Financial Products Inc (6.30%) | 23,395,000 | 6.30% | 13G (passive) | Mar 31, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of BHC | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Paulson & Co. Inc. | 73,255,869 | 19.57% | $361.15M | – | 14.02% |
| Goldentree Asset Management LP | 34,665,731 | 9.26% | $170.71M | – | 9.92% |
| Royal Bank of Canada | 10,832,582 | 2.89% | $53.40M | −530,916 | 0.01% |
| Healthcare Of Ontario Pension Plan Trust Fund | 8,000,000 | 2.14% | $39.44M | – | 0.06% |
| Vanguard Capital Management LLC | 7,465,468 | 1.99% | $36.80M | +61,709 | 0.00% |
| Goldman Sachs Group Inc | 6,225,131 | 1.66% | $30.69M | +1,017,165 | 0.00% |
| MFN Partners Management, LP | 6,000,000 | 1.60% | $29.58M | – | 0.61% |
| SG Americas Securities, LLC | 5,535,771 | 1.48% | $27.29M | +5,520,961 | 0.02% |
| Acadian Asset Management LLC | 5,482,986 | 1.46% | $26.98M | +603,501 | 0.03% |
| Kohlberg Kravis Roberts & Co. L.P. | 5,235,000 | 1.40% | $25.81M | – | 0.45% |
| Ing Groep Nv | 5,000,000 | 1.34% | $24.65M | – | 0.12% |
| Hudson Bay Capital Management LP | 5,000,000 | 1.34% | $24.65M | – | 0.07% |
| Geode Capital Management, LLC | 4,803,485 | 1.28% | $33.17M | +574,614 | 0.00% |
| Gendell Jeffrey L | 4,037,091 | 1.08% | $19.90M | +1,067,251 | 0.18% |
| Norges Bank | 3,431,117 | 0.92% | $16.91M | New | 0.00% |
| Macquarie Group Ltd | 3,250,000 | 0.87% | $16.02M | – | 0.07% |
| Dimensional Fund Advisors LP | 3,241,140 | 0.87% | $15.98M | −363,678 | 0.00% |
| D. E. Shaw & Co., Inc. | 2,689,942 | 0.72% | $13.26M | +2,068,187 | 0.01% |
| Vanguard Fiduciary Trust Co | 2,250,910 | 0.60% | $11.09M | +29,745 | 0.00% |
| Point72 Asset Management, L.P. | 2,235,821 | 0.60% | $11.02M | +885,559 | 0.01% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 220 | 237M | 63.4% | 29 / 69 | 63 / 34 | 23M | 19M |
| Q1 2026 | 226 | 233M | 62.2% | 29 / 84 | 59 / 34 | 31M | 23M |
| Q4 2025 | 235 | 236M | 63.0% | 51 / 84 | 51 / 28 | 30M | 35M |
| Q3 2025 | 217 | 241M | 64.3% | 35 / 57 | 65 / 26 | 53M | 68M |
| Q2 2025 | 210 | 256M | 68.3% | 27 / 61 | 64 / 43 | 33M | 21M |
| Q1 2025 | 228 | 244M | 65.1% | 36 / 67 | 67 / 29 | 29M | 39M |
| Q4 2024 | 223 | 254M | 67.8% | 39 / 52 | 76 / 24 | 16M | 17M |
| Q3 2024 | 210 | 255M | 68.1% | 27 / 45 | 71 / 49 | 25M | 50M |
| Q2 2024 | 233 | 281M | 75.0% | 38 / 60 | 75 / 37 | 25M | 32M |
| Q1 2024 | 235 | 288M | 76.8% | 36 / 49 | 70 / 33 | 21M | 22M |
| Q4 2023 | 233 | 289M | 77.1% | 41 / 52 | 71 / 28 | 33M | 39M |
| Q3 2023 | 222 | 294M | 78.7% | 32 / 48 | 71 / 38 | 49M | 21M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
63 funds held BHC in Q2 2026, 72% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Thomas Appio | Chief Executive Officer, Director | 3,453,236 | 0.92% | Mar 3, 2026 |
| Aimee J. Lenar | President, US Pharma | 334,853 | 0.09% | Aug 20, 2026 |
| Steven Hyosig Lee | SVP, Controller & CAO | 70,114 | 0.02% | Jul 15, 2026 |
| Seana Carson | EVP, General Counsel | 616,761 | 0.16% | Mar 3, 2026 |
| Jean-Jacques Charhon | EVP, CFO | 706,478 | 0.19% | Mar 3, 2026 |
| John S. Barresi | SVP, Controller & CAO | 197,364 | 0.05% | Mar 3, 2025 |
| Sandra Leung | Director | 102,859 | 0.03% | Oct 2, 2026 |
| John Paulson | Director | 73,696,831 | 19.69% | Oct 2, 2026 |
| Amy B. Wechsler | Director | 316,158 | 0.08% | Oct 2, 2026 |
| Sarah B. Kavanagh | Director | 282,230 | 0.08% | May 26, 2026 |
| Robert N. Power | Director | 300,594 | 0.08% | May 26, 2026 |
| Christian A. Garcia | Director | 135,578 | 0.04% | May 26, 2026 |
| Eiry Roberts | Director | 45,871 | 0.01% | May 26, 2026 |
| Michael Goettler | Director | 76,020 | 0.02% | May 26, 2026 |
| Frank D. Lee | Director | 95,210 | 0.03% | May 26, 2026 |
| Brett Icahn | Director | 220,280 | 0.06% | Jul 2, 2025 |
| Steven D. Miller | Director | 239,224 | 0.06% | May 20, 2025 |
| Richard Mulligan | Director | 155,616 | 0.04% | May 20, 2025 |
| & Co. Inc. Paulson | 10% owner | 73,255,869 | 19.57% | Nov 28, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| John Paulson Director | Sep 30, 2026 | Award | +10,720 | $5.83 | $62.50K | 440,962 |
| Sandra Leung Director | Sep 30, 2026 | Award | +5,789 | $5.83 | $33.75K | 102,859 |
| Amy B. Wechsler Director | Sep 30, 2026 | Award | +1,179 | $5.83 | $6.87K | 316,158 |
| Aimee J. Lenar President, US Pharma | Aug 19, 2026 | Sale(10b5-1 plan) | −36,827 | $7.03 | $258.89K | 334,853 |
| Aimee J. Lenar President, US Pharma | Jul 17, 2026 | Tax withholding | −5,260 | $4.83 | $25.41K | 371,680 |
| Aimee J. Lenar President, US Pharma | Jul 15, 2026 | Tax withholding | −23,395 | $4.89 | $114.40K | 376,940 |
| Steven Hyosig Lee SVP, Controller & CAO | Jul 14, 2026 | Tax withholding | −3,125 | $4.75 | $14.84K | 70,114 |
| Amy B. Wechsler Director | Jun 30, 2026 | Award | +1,394 | $4.93 | $6.87K | 314,979 |
| Sandra Leung Director | Jun 30, 2026 | Award | +6,845 | $4.93 | $33.75K | 97,070 |
| John Paulson Director | Jun 30, 2026 | Award | +12,677 | $4.93 | $62.50K | 430,242 |
| Michael Goettler Director | May 22, 2026 | Award | +45,871 | – | – | 76,020 |
| Sandra Leung Director | May 22, 2026 | Award | +45,871 | – | – | 90,225 |
| Robert N. Power Director | May 22, 2026 | Award | +45,871 | – | – | 300,594 |
| John Paulson Director | May 22, 2026 | Award | +45,871 | – | – | 417,565 |
| Amy B. Wechsler Director | May 22, 2026 | Award | +45,871 | – | – | 313,585 |
| Frank D. Lee Director | May 22, 2026 | Award | +45,871 | – | – | 95,210 |
| Eiry Roberts Director | May 22, 2026 | Award | +45,871 | – | – | 45,871 |
| Christian A. Garcia Director | May 22, 2026 | Award | +45,871 | – | – | 135,578 |
| Sarah B. Kavanagh Director | May 22, 2026 | Award | +45,871 | – | – | 282,230 |
| Frank D. Lee Director | May 19, 2026 | Sale(10b5-1 plan) | −24,456 | $5.43 | $132.80K | 49,339 |
| Sandra Leung Director | Mar 31, 2026 | Award | +5,946 | $5.40 | $32.11K | 44,354 |
| Amy B. Wechsler Director | Mar 31, 2026 | Award | +1,273 | $5.40 | $6.87K | 267,714 |
| John Paulson Director | Mar 31, 2026 | Award | +11,574 | $5.40 | $62.50K | 371,694 |
| Seana Carson EVP, General Counsel | Mar 3, 2026 | Sale(10b5-1 plan) | −4,420 | $5.77 | $25.50K | 616,761 |
| Seana Carson EVP, General Counsel | Mar 2, 2026 | Other | −137,922 | $5.95 | $820.64K | 621,181 |
| Seana Carson EVP, General Counsel | Mar 2, 2026 | Tax withholding | −16,973 | $5.95 | $100.99K | 759,103 |
| Seana Carson EVP, General Counsel | Mar 2, 2026 | Sale(10b5-1 plan) | −6,856 | $5.78 | $39.63K | 776,076 |
| Thomas Appio Chief Executive Officer, Director | Mar 2, 2026 | Tax withholding | −83,705 | $5.95 | $498.04K | 3,453,236 |
| Thomas Appio Chief Executive Officer, Director | Mar 2, 2026 | Other | −1,137,862 | $5.95 | $6.77M | 2,315,374 |
| Seana Carson EVP, General Counsel | Feb 27, 2026 | Tax withholding | −26,326 | $5.93 | $156.11K | 782,932 |
| Thomas Appio Chief Executive Officer, Director | Feb 27, 2026 | Tax withholding | −83,093 | $5.93 | $492.74K | 3,536,941 |
| Jean-Jacques Charhon EVP, CFO | Feb 27, 2026 | Tax withholding | −49,060 | $5.93 | $290.93K | 706,478 |
| Seana Carson EVP, General Counsel | Feb 27, 2026 | Sale(10b5-1 plan) | −8,388 | $5.95 | $49.91K | 809,258 |
| Thomas Appio Chief Executive Officer, Director | Feb 26, 2026 | Tax withholding | −116,502 | $6.04 | $703.67K | 3,620,034 |
| Seana Carson EVP, General Counsel | Feb 26, 2026 | Tax withholding | −32,211 | $6.04 | $194.55K | 817,646 |
| Aimee J. Lenar EVP, US Pharma | Feb 26, 2026 | Tax withholding | −17,578 | $6.04 | $106.17K | 400,335 |
| Jean-Jacques Charhon EVP, CFO | Feb 26, 2026 | Tax withholding | −35,977 | $6.04 | $217.30K | 755,538 |
| Thomas Appio Chief Executive Officer, Director | Feb 25, 2026 | Award | +815,425 | – | – | 3,736,536 |
| Seana Carson EVP, General Counsel | Feb 25, 2026 | Award | +212,350 | – | – | 849,857 |
| Steven Hyosig Lee SVP, Controller & CAO | Feb 25, 2026 | Award | +45,868 | – | – | 73,239 |
| Aimee J. Lenar EVP, US Pharma | Feb 25, 2026 | Award | +157,139 | – | – | 417,913 |
| Jean-Jacques Charhon EVP, CFO | Feb 25, 2026 | Award | +276,055 | – | – | 791,515 |
| Thomas Appio Chief Executive Officer, Director | Feb 9, 2026 | Award | +1,137,862 | – | – | 2,921,111 |
| Seana Carson EVP, General Counsel | Feb 9, 2026 | Award | +137,922 | – | – | 637,507 |
| John Paulson Director | Dec 31, 2025 | Award | +8,992 | – | – | 360,120 |
| Sandra Leung Director | Dec 31, 2025 | Award | +4,586 | – | – | 38,408 |
| Amy B. Wechsler Director | Dec 31, 2025 | Award | +989 | – | – | 266,441 |
| & Co. Inc. Paulson 10% owner | Nov 25, 2025 | Buy | +2,500,000 | $6.25 | $15.63M | 73,255,869 |
| Amy B. Wechsler Director | Sep 30, 2025 | Award | +1,065 | – | – | 265,452 |
| Sandra Leung Director | Sep 30, 2025 | Award | +3,673 | – | – | 33,822 |
| John Paulson Director | Sep 30, 2025 | Award | +9,689 | – | – | 351,128 |
| Seana Carson EVP, General Counsel | Sep 8, 2025 | Sale(10b5-1 plan) | −13,370 | $7.31 | $97.73K | 499,585 |
| Seana Carson EVP, General Counsel | Sep 5, 2025 | Tax withholding | −51,337 | $7.35 | $377.33K | 512,955 |
| Frank D. Lee Director | Aug 21, 2025 | Sale | −15,912 | $7.66 | $121.89K | 73,795 |
| John Paulson Director | Aug 14, 2025 | Buy | +34,721,118 | $9.00 | $312.49M | 70,755,869 |
| John Paulson Director | Aug 13, 2025 | Buy | +86,409 | $7.06 | $610.05K | 36,034,751 |
| John Paulson Director | Aug 12, 2025 | Buy | +1,156,640 | $6.88 | $7.96M | 35,948,342 |
| John Paulson Director | Aug 11, 2025 | Buy | +2,000,000 | $6.35 | $12.70M | 34,791,702 |
| Michael Goettler Director | Jul 25, 2025 | Award | +30,149 | – | – | 30,149 |
| Sandra Leung Director | Jul 25, 2025 | Award | +30,149 | – | – | 30,149 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Bausch Health Companies's stock actually held short. Settlement fails (shares not delivered on time) peaked at 450,836 shares on Sep 1, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Aimee J. Lenar Officer | Aug 19, 2026 | 36,827 | $258.89K | Aug 19, 2026 | Restricted Stock Vesting |
| Frank D. Lee Director | May 19, 2026 | 24,456 | $132.80K | May 19, 2026 | Restricted Stock Vesting |
| Seana Carson Officer | Mar 3, 2026 | 4,420 | $25.50K | Mar 3, 2026 | Restricted Stock Vesting |
| Seana Carson Officer | Mar 2, 2026 | 6,856 | $39.63K | Mar 2, 2026 | Restricted Stock Vesting |
| Seana Carson Officer | Feb 27, 2026 | 8,388 | $49.91K | Feb 27, 2026 | Restricted Stock Vesting |
| Seana Carson Officer | Sep 8, 2025 | 13,370 | $97.73K | Sep 8, 2025 | Restricted Stock Vesting |
| Frank D. Lee Director | Aug 21, 2025 | 15,912 | $121.89K | Aug 21, 2025 | Restricted Stock Vesting |
| Seana Carson Officer | Dec 2, 2024 | 440 | $3.67K | Dec 2, 2024 | Restricted Stock Vesting |
| Seana Carson Officer | Sep 6, 2024 | 13,370 | $83.03K | Sep 6, 2024 | Restricted Stock Vesting |
| Seana Carson Officer | Mar 4, 2024 | 6,313 | $61.87K | Mar 4, 2024 | Restricted Stock Vesting |
| Seana Carson Officer | Dec 5, 2023 | 220 | $1.62K | Dec 5, 2023 | Restricted Stock Vesting |
| Seana Carson Officer | Nov 6, 2023 | 43 | $327 | Nov 6, 2023 | Restricted Stock Vesting |
| Seana Carson Officer | Sep 6, 2023 | 6,685 | $55.35K | Sep 6, 2023 | Restricted Stock Vesting |
See a number that looks wrong?